China Health Group Limited (0673.HK)
HKD 0.54
(-12.9%)
HKD 0.54
(-12.9%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.62 Million | -8.22 Million | 31.79 Million | -9.06 Million | -21.76 Million | -17.3 Million |
| Net Income | -40.18 Million | -42.04 Million | -12.2 Million | -7.74 Million | -36.67 Million | -23.08 Million |
| Depreciation & Amortization | 4.54 Million | 4.15 Million | 4.03 Million | 3.57 Million | 2.5 Million | 1.67 Million |
| Deferred income taxes | - | -26.61 Million | 39.12 Million | -24.48 Million | -24.51 Million | - |
| Stock-based compensation | - | 23 Thousand | 773 Thousand | 895 Thousand | 9.92 Million | - |
| Change in working capital | 20.65 Million | 10.06 Million | 37.16 Million | 2.47 Million | -10.03 Million | -16.92 Million |
| Other non-cash items | 24.64 Million | 46.19 Million | -37.08 Million | 16.21 Million | 37.03 Million | 21.02 Million |
| Investing Cash Flow | -307 Thousand | -5.4 Million | -35.28 Million | -1.84 Million | -1.7 Million | 534 Thousand |
| Investments in PPE | -624 Thousand | -1.36 Million | -795 Thousand | -1.84 Million | -427 Thousand | - |
| Acquisitions | 317 Thousand | -4 Million | -15.96 Million | - | -1.27 Million | 1.56 Million |
| Investment purchases | - | -4 Million | -18.53 Million | - | - | - |
| Sales/Maturities of investments | - | - | 18.53 Million | - | - | - |
| Other Investing Activities | -63 Thousand | -32 Thousand | -18.53 Million | 8000.00 | 530 Thousand | -1.02 Million |
| Financing Cash Flow | -1.01 Million | 27.66 Million | 12.96 Million | 2.63 Million | 3.88 Million | 6.96 Million |
| Debt repayment | -25 Thousand | -18.14 Million | -14.06 Million | -3.55 Million | -717 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 40 Million | - | - | 4.6 Million | 5.4 Million |
| Other Financing Activities | -204 Thousand | 45.8 Million | 27.02 Million | 6.18 Million | 5.69 Million | 1.56 Million |
| Accounts receivables | -8.43 Million | 8.29 Million | 49.69 Million | -20.9 Million | -2.18 Million | -16.96 Million |
| Accounts payables | 8.85 Million | 4.95 Million | -60 Thousand | 2.98 Million | -823 Thousand | 4.28 Million |
| Inventory | -7.61 Million | 1.76 Million | -1.67 Million | 1.48 Million | -6.57 Million | 37 Thousand |
| Other working capital | 27.84 Million | -17.31 Million | -10.8 Million | 18.91 Million | -458 Thousand | -4.28 Million |
| Cash at beginning of period | 11.48 Million | 8.53 Million | 4.59 Million | 10.24 Million | 29.93 Million | 38.99 Million |
| Cash at end of period | 4.01 Million | 11.48 Million | 8.53 Million | 4.59 Million | 10.24 Million | 29.93 Million |
| Capital Expenditure | -624 Thousand | -1.36 Million | -795 Thousand | -1.84 Million | -427 Thousand | - |
| Effect of forex changes on cash | 476 Thousand | -11.09 Million | -5.53 Million | 2.62 Million | -112 Thousand | 746 Thousand |
| Net cash flow / Change in cash | -7.46 Million | 2.94 Million | 3.94 Million | -5.65 Million | -19.68 Million | -9.06 Million |
| Free Cash Flow | -7.25 Million | -9.58 Million | 31 Million | -10.9 Million | -22.18 Million | -17.3 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -40.18 Million | -25.12 Million | -15.06 Million | -42.04 Million | -14.43 Million | -27.61 Million |
| Depreciation & Amortization | 4.54 Million | 2.44 Million | 1.74 Million | 4.15 Million | 1.55 Million | 2.59 Million |
| Deferred income taxes | - | - | - | -26.61 Million | - | - |
| Stock-based compensation | - | - | - | 23 Thousand | - | 23 Thousand |
| Change in working capital | 20.65 Million | 11.97 Million | - | 10.06 Million | -18.94 Million | - |
| Other non-cash items | 24.64 Million | 19.19 Million | 1.91 Million | 46.19 Million | 13.07 Million | 24.89 Million |
| Investing Cash Flow | -307 Thousand | -30 Thousand | -271 Thousand | -5.4 Million | -1.11 Million | -4.72 Million |
| Investments in PPE | -624 Thousand | -624 Thousand | - | -1.36 Million | -1.36 Million | - |
| Acquisitions | 317 Thousand | 386 Thousand | - | -4 Million | - | - |
| Investment purchases | - | - | - | -4 Million | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -63 Thousand | 208 Thousand | -271 Thousand | -32 Thousand | 1.19 Million | -4.72 Million |
| Financing Cash Flow | -1.01 Million | -8.31 Million | 7.07 Million | 27.66 Million | 5.01 Million | 23.09 Million |
| Debt repayment | -25 Thousand | - | - | -18.14 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -8.92 Million | - | - | -19.93 Million | - |
| Common Stock Issuance | - | - | - | 40 Million | - | - |
| Other Financing Activities | -204 Thousand | 614 Thousand | 7.07 Million | 45.8 Million | 23.93 Million | 23.09 Million |
| Accounts receivables | -8.43 Million | -1.12 Million | - | 8.29 Million | 5.78 Million | - |
| Accounts payables | 8.85 Million | - | - | 4.95 Million | - | - |
| Inventory | -7.61 Million | -7.61 Million | - | 1.76 Million | 816 Thousand | - |
| Other working capital | 27.84 Million | 20.71 Million | - | -17.31 Million | -25.55 Million | - |
| Cash at beginning of period | 11.48 Million | 3.25 Million | 11.48 Million | 8.53 Million | 22.74 Million | 8.53 Million |
| Cash at end of period | 4.01 Million | 4.01 Million | 3.25 Million | 11.48 Million | 11.48 Million | 22.74 Million |
| Capital Expenditure | -624 Thousand | -624 Thousand | - | -1.36 Million | -1.36 Million | - |
| Effect of forex changes on cash | 476 Thousand | 612 Thousand | -136 Thousand | -11.09 Million | -798 Thousand | 1.15 Million |
| Net cash flow / Change in cash | -7.46 Million | 758 Thousand | -8.22 Million | 2.94 Million | -11.26 Million | 14.2 Million |
| Free Cash Flow | -7.25 Million | 7.86 Million | -14.89 Million | -9.58 Million | -4.28 Million | -5.32 Million |
MOL
9045
ESNC
603088
3252
NDL